J. B. Alarcon

DNA vaccines: technology and application as anti-parasite and anti-microbial agents.

D. McManus, J. Alarcon, G. Waine, 1999, Advances in parasitology.

Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates

Cheryl H. Dean, F. Guirakhoo, T. Monath, 2005, Human vaccines.

Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines

N. Harvey, J. Mikszta, J. B. Alarcon, 2007, Clinical and Vaccine Immunology.

Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.

Vincent J. Sullivan, Cheryl H. Dean, J. Dekker, 2005, The Journal of infectious diseases.

Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery

Diane E. Sutter, J. Alarcon, N. Harvey, 2002, Nature Medicine.

Protective Immunity in Mice Achieved with Dry Powder Formulation and Alternative Delivery of Plague F1-V Vaccine

Vincent J. Sullivan, J. Alarcon, R. Ulrich, 2009, Clinical and Vaccine Immunology.

An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock

Leonard A. Smith, P. Worsham, J. Alarcon, 2008, Journal of immune based therapies and vaccines.

A retrospective matched‐cohort study of 3994 lower extremity wounds of multiple etiologies across 644 institutions comparing a bioactive human skin allograft, TheraSkin, plus standard of care, to standard of care alone

G. Gurtner, J. Alarcon, A. Garcia, 2019, International wound journal.